Inactivated Polio Vaccine Market
Inactivated Polio Vaccine Market Size And Forecast
According To Verified Market Research, Global Inactivated Polio Vaccine Market is growing at a faster pace with substantial growth rates over the last few years and is estimated that the market will grow significantly in the forecasted period i.e. 2019 to 2026.
Global Inactivated Polio Vaccine Market Outlook
The phased withdrawal of the oral polio vaccine (OPV) worldwide has surged the demand for inactivated polio vaccine (IPV) in the market. According to the recommendations made by the World Health Organization (WHO) to introduce at least one dose of IPV in their routine immunization programs has fuelled the inactivated polio vaccine market. IPV is considered to be safe with extremely rare severe adverse reactions, therefore boosting the market. However, IPV is over five times more expensive than OPV and therefore it is a major restraining factor of the market.
Global Inactivated Polio Vaccine Market Competitive Landscape
The Global Inactivated Polio Vaccine Market study report will provide a valuable insight with an emphasis on the global market including some of the major players such as GlaxoSmithKline, Sanofi, Astellas Pharma, Serum Institute of India Pvt. Ltd., Panacea Biotec Ltd., Bilthoven Biologicals.
Verified Market Research has been providing Research Reports, with up to date information, and in-depth analysis, for several years now, to individuals and companies alike that are looking for accurate Research Data. It has large database which includes the latest content from renowned authors and publications worldwide. It also provides customized Data and Reports according to the need of the client.